RUBIUS
Live / Registered — Registered (as of 17 Mar 2020)
What this means for you
Registered since 17 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87641893
- Registration number
- 6014060
- Mark type
- Stylized text
- Filed
- 11 Oct 2017
- Published for opposition
- 12 Jun 2018
- Registered
- 17 Mar 2020
- Attorney of record
- Christina M. Licursi, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders; pharmaceutical preparations of cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders
Owner
- Rubius Therapeutics, Inc., Cambridge, MA, US
- Rubius Therapeutics, Inc., Cambridge, MA, US
- Rubius Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 17 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 12 Feb 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Feb 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Feb 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Feb 2020 — USE AMENDMENT FILED
- 11 Feb 2020 — SOU EXTENSION 3 GRANTED
- 07 Feb 2020 — SOU EXTENSION 3 FILED
- 07 Feb 2020 — SOU TEAS EXTENSION RECEIVED
- 07 Feb 2020 — TEAS STATEMENT OF USE RECEIVED
- 14 Aug 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Aug 2019 — SOU EXTENSION 2 GRANTED
- 07 Aug 2019 — SOU EXTENSION 2 FILED
- 13 Aug 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL